Venture Capital

 

Capital Access; Life Science; Venture Capital
July 19, 2012 Posted by
Continued Rebound: Trends in Life Science M&A" examines merger and acquisition trends for private, venture capital-backed biotech and medical device companies. The analysis of the data shows positive momentum in life science exits, positioning life science as an attractive investment opportunity now and in the future.
Read More
0 Comments | Join the Discussion

Venture Capital
December 08, 2011 Posted by
Some have labeled the last ten years in the venture capital industry a decade of lost returns. Ten and 11-year industry benchmarks show a negative Internal Rate of Return (IRR) causing some investors to question if the venture capital model is broken and in need of dramatic overhaul.
Read More
0 Comments | Join the Discussion

Venture Capital
June 03, 2011 Posted by
Today’s entrepreneurial companies face greater pressure to do more with less in terms of stretching every dollar of equity financing further.
Read More
0 Comments | Join the Discussion

FX Outlook; Venture Capital; Europe
April 11, 2011 Posted by
The role played by entrepreneurship in bolstering the UK economy has been the subject of much interest and debate over the course of recent months. A number of new initiatives designed to promote and encourage entrepreneurial activity have been unveiled, including tax breaks, visas for entrepreneurs and the re-development of London's Olympic site into a technology city to rival the Valley.
Read More
0 Comments | Join the Discussion

Venture Capital; Europe
March 08, 2011 Posted by
Hermann Hauser, a technology pioneer and leader in the United Kingdom venture community, as the co-founder of Amadeus Capital Partners provides insight into UK investment, promising technologies and the role of academics in developing startups ...
Read More
0 Comments | Join the Discussion

Life Science; Startups; Venture Capital
November 08, 2010 Posted by
Venture capitalists and startup company executives who attended the latest Silicon Valley Bank SVB Showcase event were generally upbeat about prospects for  technology, life science and cleantech innovation and investment. The quarterly invitation-only pitch event brought together dozens of people from early and growth stage companies seeking to raise their next round of funding, and from venture capitalist firms.
Read More
0 Comments | Join the Discussion

Analytics; Venture Capital
October 08, 2010 Posted by
We have analyzed data over the last 15 years for venture capital investing and the performance related to those activities. While it is clear from this analysis that the halcyon days were from 1994-2000, there are some very positive signs that the industry is still very much an attractive asset class.
Read More
3 Comments | Join the Discussion

Analytics; Life Science; Venture Capital
October 08, 2010 Posted by
SVB Analytics' Web seminar focuses on trends in the Life Science sector, including venture capital financing, M&A, and IPO activity.  In this free replay of the seminar, you will hear a variety of viewpoints from our expert panel of venture capitalists who have investment experience in the Life Science sector, as well as valuation and research professionals from SVB.
Read More
0 Comments | Join the Discussion

Life Science; Venture Capital
September 03, 2010 Posted by

Have you wondered how many really good life science M&A exits happen every year? Are the big guys even buying? Do these exits actually provide returns that materially affect the venture funds that are investing?

Read More
2 Comments | Join the Discussion